Coronavirus: NAFDAC Approves Production Of Chloroquine For Clinical Trial
The National Agency for Food and Drug Administration and Control (NAFDAC) has approved the production of Chloroquine for clinical trials in the search for a cure for COVID-19.
Director-General of the agency, Mojisola Adeyeye, made the announcement on Friday at the NAFDAC headquarters in Lagos.
She, however, pointed out that NAFDAC is not approving Chloroquine for the treatment of COVID-19 but for clinical trials to find treatment for the virus.
“NAFDAC is not approving Chloroquine as a product that has can be used for Coronavirus because there is no submission to us for registration but because it is under clinical trials, NAFDAC approves medicines meant for clinical trials.
“Therefore the medicine is being approved just for the clinical trials,” Adeyeye said.
She, therefore, called on experts and researchers that are interested in doing a clinical trial on Chloroquine to approach approved outlets.
“Right now, we have asked one company to make a batch of Chloroquine for the purpose of clinical trial,” Adeyeye added.
Post Views: 8
You may be interested
Heartbreaking Photos Of John Legend And Wife Mourning After Losing Newborn Son Moments After He Was BornWebby - October 1, 2020
John Legend and wife Chrissy Singer John Legend and Wife, Chrissy Teigen are mourning after losing their baby boy just…
Kevin Hart And Wife, Eniko Parrish, Welcome Baby DaughterWebby - October 1, 2020
Comedian Kevin Hart and his wife Eniko Parrish Hart are celebrating the birth of their second child together, a baby…
Shocking Story Of Cultist Who Sexually Assaulted His Own Daughters From The Age Of 4Webby - October 1, 2020
The vile pervert has been caged after sexually abusing his own daughters and sister in Australia (file photo) A cult…